A key skin protein may control immune overreactions, explaining painful rare conditions and pointing to new treatment paths ...

Poster #76954 highlights QTORIN™ rapamycin’s single phase anhydrous gel formulation designed to optimize dermal bioavailability of rapamycin for mTOR-driven skin diseases while overcoming the ...

Physician and seasoned life sciences investor with more than two decades of experience across clinical practice, biotechnology investing, and ...

Throughout his young life, John Hudson Dilgen was also well-known on Staten Island for his generosity, kindness, bravery and ...

Founded and led by rare disease biotech veterans, Palvella Therapeutics, Inc. (Nasdaq: PVLA) is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to ...

Medicus Pharma (NASDAQ:MDCX) said on Friday it has submitted an application to the US Food and Drug Administration seeking ...

SALT LAKE CITY (KTVX) — A Utah woman is sharing her story after she survived an incredibly rare and often fatal skin disorder caused by an allergic reaction to antibiotics. “I’m lucky to be alive, I’m ...

SALT LAKE CITY (KTVX) — A Utah woman is sharing her story after she survived an incredibly rare and often fatal skin disorder caused by an allergic reaction to antibiotics. “I’m lucky to be alive, I’m ...

Muhammad Taluli arrived from Gaza at Jerusalem's Hadassah Medical Center a few months ago and unwrapped the cloth from his hands to reveal gray and white growths that looked like tree bark. The ...

SALT LAKE CITY (KTVX) — A Utah woman is sharing her story after she survived an incredibly rare and often fatal skin disorder caused by an allergic reaction to antibiotics. “I’m lucky to be alive, I’m ...